Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences

Journal of Neuroscience

Volumn 26, Issue 22, 2006, Pages 6031-6039

  Youngs, Rachael M ^a   Chu, Melissa S ^a   Meloni, Edward G ^a,b   Naydenov, Alipi ^a   Carlezon Jr , William A ^a,b   Konradi, Christine ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amygdala; Anxiety; Behavior; Development; Elevated plus maze; Gene expression microarrays; Lithium

Indexed keywords

LITHIUM; RNA;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BIPOLAR DISORDER; BRAIN DEVELOPMENT; CELL ADHESION; CONTROLLED STUDY; CYTOSKELETON; DRUG BLOOD LEVEL; DRUG EFFECT; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC TRANSCRIPTION; JUVENILE; MAZE TEST; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPSE; WEIGHT GAIN; ADULT; ANIMAL; BRAIN; CHEMICALLY INDUCED DISORDER; CHILD; DISEASE MODEL; DNA MICROARRAY; FEAR; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MOTOR ACTIVITY; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STARTLE REFLEX;

ADMINISTRATION, ORAL; ADULT; ANIMALS; ANXIETY; BIPOLAR DISORDER; BRAIN; CHILD; DISEASE MODELS, ANIMAL; FEAR; GENE EXPRESSION REGULATION; HUMANS; LITHIUM; MALE; MAZE LEARNING; MOTOR ACTIVITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA; STARTLE REACTION;

EID: 33745246067     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0580-06.2006     Document Type: Article

References (64)

1. Alonso T, Morgan RO, Marvizon JC, Zarbl H, Santos E (1988) Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways. Proc Natl Acad Sci USA 85:4271-4275.
2. American Psychiatric Association (1994) Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. Am J Psychiatry 151:1-36.
3. Andersen SL (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27:3-18.
4. Bailey CH, Bartsch D, Kandel ER (1996) Toward a molecular definition of long-term memory storage. Proc Natl Acad Sci USA 93:13445-13452.
5. Baraban JM, Worley PF, Snyder SH (1989) Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium. Am J Psychiatry 146:1251-1260.
6. Berridge MJ, Downes CP, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206:587-595.
7. Berry GT, Buccafusca R, Greer JJ, Eccleston E (2004) Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain. Mol Genet Metab 82:87-92.
8. Biederman J, Mick E, Bostic JQ, Prince J, Daly J, Wilens TE, Spencer T, Garcia-Jetton J, Russell R, Wozniak J, Faraone SV (1998) The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. J Clin Psychiatry 59:628-637; quiz 638.
9. Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J (2005) Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry 58:589-594.
10. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
11. Brandish PE, Su M, Holder DJ, Hodor P, Szumiloski J, Kleinhanz RR, Forbes JE, McWhorter ME, Duenwald SJ, Parrish ML, Na S, Liu Y, Phillips RL, Renger JJ, Sankaranarayanan S, Simon AJ, Scolnick EM (2005) Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex. Neuron 45:861-872.
12. Brett RR, Pratt JA (1990) Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze. Eur J Pharmacol 178:135-138.
13. Brown JS, Kalish HI, Farber IE (1951) Conditioned fear as revealed by magnitude of startle response to an auditory stimulus. J Exp Psychol 41:317-328.
14. Cappeliez P (1986) Comparing oral lithium carbonate and intraperitoneal lithium chloride chronic administrations on rats' activity levels. Neuropsychobiology 16:103-108.
15. Carlezon Jr WA, Konradi C (2004) Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 47 [Suppl 1]:47-60.
16. Carlezon Jr WA, William A, Rohan ML, Mague SD, Meloni EG, Parsegian A, Cayetano K, Tomasiewicz HC, Rouse ED, Cohen BM, Renshaw PF (2005) Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol Psychiatry 57:571-576.
17. Carlson GA (1990) Child and adolescent mania-diagnostic considerations. J Child Psychol Psychiatry 31:331-341.
18. Carlson GA, Davenport YB, Jamison K (1977) A comparison of outcome in adolescent- and later-onset bipolar manic-depressive illness. Am J Psychiatry 134:919-922.
19. Chang K, Karchemskiy A, Barnea-Goraly N, Garrett A, Simeonova DI, Reiss A (2005) Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:565-573.
20. Crawley JN (1985) Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9:37-44.
21. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31:19-20.
22. Davanzo PA, McCracken JT (2000) Mood stabilizers in the treatment of juvenile bipolar disorder. Advances and controversies. Child Adolesc Psychiatr Clin N Am 9:159-182.
23. Davis M (1997) Neurobiology of fear responses: the role of the amygdala. J Neuropsychiatry Clin Neurosci 9:382-402.
24. Davis M, Astrachan DI (1978) Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training. J Exp Psychol Anim Behav Process 4:95-103.
25. Dawson GR, Tricklebank MD (1995) Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16:33-36.
26. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.
27. Dickstein DP, Rich BA, Binstock AB, Pradella AG, Towbin KE, Pine DS, Leibenluft E (2005) Comorbid anxiety in phenotypes of pediatric bipolar disorder. J Child Adolesc Psychopharmacol 15:534-548.
28. D'Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 36:60-90.
29. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR (2003) MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4:R7.
30. Engstrom C, Brandstrom S, Sigvardsson S, Cloninger R, Nylander PO (2003) Bipolar disorder. II. Personality and age of onset. Bipolar Disord 5:340-348.
31. Geller B, Luby J (1997) Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 36:1168-1176.
32. Geller B, Sun K, Zimerman B, Luby J, Frazier J, Williams M (1995) Complex and rapid-cycling in bipolar children and adolescents: a preliminary study. J Affect Disord 34:259-268.
33. Geller B, Williams M, Zimerman B, Frazier J, Beringer L, Warner KL (1998) Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J Affect Disord 51:81-91.
34. Grillon C, Davis M (1997) Fear-potentiated startle conditioning in humans: explicit and contextual cue conditioning following paired versus unpaired training. Psychophysiology 34:451-458.
35. Harpaz-Rotem I, Leslie DL, Martin A, Rosenheck RA (2005) Changes in child and adolescent inpatient psychiatric admission diagnoses between 1995 and 2000. Soc Psychiatry Psychiatr Epidemiol 40:642-647.
36. Harwood AJ (2005) Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiatry 10:117-126.
37. Hechtman L, Greenfield B (1997) Juvenile onset bipolar disorder. Curr Opin Pediatr 9:346-353.
38. Huang M, Chida K, Kamata N, Nose K, Kato M, Homma Y, Takenawa T, Kuroki T (1988) Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts. J Biol Chem 263:17975-17980.
39. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
40. Joyce PR (1984) Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia. Psychol Med 14:145-149.
41. Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM (2003) Lithium treatment of acute mania in adolescents: a large open trial. J Am Acad Child Adolesc Psychiatry 42:1038-1045.
42. Klann E, Dever TE (2004) Biochemical mechanisms for translational regulation in synaptic plasticity. Nat Rev Neurosci 5:931-942.
43. Konradi C (2005) Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Brain Res Rev 50:142-155.
44. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ (2000) Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39:713-720.
45. Laursen UH, Pihakaski-Maunsbach K, Kwon TH, Ostergaard Jensen E, Nielsen S, Maunsbach AB (2004) Changes of rat kidney AQP2 and Na, K-ATPase mRNA expression in lithium-induced nephrogenic diabetes insipidus. Nephron Exp Nephrol 97:E1-E16.
46. LeDoux J (2003) The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23:727-738.
47. Lee RV, Jampol LM, Brown WV (1971) Nephrogenic diabetes insipidus and lithium intoxication-complications of lithium carbonate therapy. N Engl J Med 284:93-94.
48. Lewinsohn PM, Klein DN, Seeley JR (1995) Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 34:454-463.
49. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31-36.
50. MacDonald ML, Eaton ME, Dudman JT, Konradi C (2004) Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiatry 57:1041-1051.
51. Masi G, Toni C, Perugi G, Mucci M, Millepiedi S, Akiskal HS (2001) Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Can J Psychiatry 46:797-802.
52. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Ed 4. San Diego: Academic.
53. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167.
54. Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM, Rosenbaum JF (2002) Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 159:1155-1159.
55. Sheard MH (1975) Lithium in the treatment of aggression. J Nerv Ment Dis 160:108-118.
56. Silva AJ (2003) Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J Neurobiol 54:224-237.
57. Silva RR, Ernst M, Campbell M (1993) Lithium and conduct disorder. Encephale 19:585-590.
58. Singer I, Rotenberg D, Puschett JB (1972) Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies. J Clin Invest 51:1081-1091.
59. Spear LP (2004) Adolescent brain development and animal models. Ann NY Acad Sci 1021:23-26.
60. Steele M, Fisman S (1997) Bipolar disorder in children and adolescents: current challenges. Can J Psychiatry 42:632-636.
61. Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plusmaze. Pharmacol Biochem Behav 44:463-469.
62. Tueth MJ, Murphy TK, Evans DL (1998) Special considerations: use of lithium in children, adolescents, and elderly populations. J Clin Psychiatry 59 [Suppl 6]:66-73.
63. Williams RS, Cheng L, Mudge AW, Harwood AJ (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417:292-295.
64. Wozniak J, Biederman J, Richards JA (2001) Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder. J Clin Psychiatry 62 [Suppl 14]:10-15.